Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery.

Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Abstract Text:

    r t suojaranta-ylinenR T Suojaranta-Ylinen,a e ventoA E Vento,t pätiläT Pätilä,s i kukkonenS I Kukkonen,

    BACKGROUND AND AIMS: Arginin vasopressin (AVP) is a potent vasoconstrictor which has been used in vasodilatory shock when therapy with catecholamines and fluids has failed. In this study we evaluated the association of AVP with organ failure and mortality in cardiac surgical patients suffering from vasodilatory shock refractory to norepinephrine (NE) treatment. MATERIAL AND METHODS: Cardiac surgical patients who received AVP in addition to NE (N=33, AVP-group) and 33 control patients (NE group) who were treated with an equal dose of NE compared with AVP patients when AVP infusion started. Data on preoperative risk factors according to EuroSCORE and predicted mortality calculated by logistic EuroSCORE were collected preoperatively. Data on hemodynamics, organ dysfunctions, length of intensive care unit stay and mortality were collected. RESULTS: EuroSCORE did not differ between the groups, AVP:10.4 +/- 3.9 vs. NE 8.9 +/- 4.0. Observed 30 day mortality was lower than predicted in both groups, AVP: 7 (21.7%) vs. predicted mortality 25.9% and NE: 2 (6.1%) vs. 16.0%, respectively. There were more renal complications (36.4% vs. 9.1%, p = 0.008) and infections (30.3% vs. 3.0%, p = 0.003) in patients receiving AVP. Cardiovascular complications did not differ between the groups. CONCLUSIONS: In this prospectively observed cohort of cardiac surgical patients, AVP did not increase mortality predicted by Euroscore. Anyhow renal and infection complications were common.

    Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Publishing Authors By Initials

    rt suojaranta-ylinenRT Suojaranta-Ylinen,ae ventoAE Vento,t pätiläT Pätilä,si kukkonenSI Kukkonen,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Scandinavian journal of surgery : SJS : official o

    VOLUME: 96

    Page Numbers: 314-8

    Journal Abbreviation:

    ISSN: 1457-4969

    DAY: 12

    MONTH: 02

    YEAR: 2007

    Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101144297

    Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery.

    AFFILIATION: Department of Anesthesia and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland. raili.suojaranta-ylinen@hus.fi

    Country: Finland

    Finland Research PublicationFinland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Scand J Surg

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Vasopressin, when added to norepinephrine, was not associated with increased predicted mortality after cardiac surgery Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News